One year of Lamivudine therapy for portuguese patients with chronic hepatitis B.

OBJECTIVE: To further verify the efficacy and safety of locally manufactured lamivudine on patients with chronic hepatitis B (CHB). METHODS: 2200 patients with CHB were recruited and received lamivudine orally 100 mg once daily for 12 months. The efficacy assessments included virologic response rate...

Full description

Bibliographic Details
Main Author: Areias, J (author)
Other Authors: Calinas, F (author), Porto, A (author), Carvalho, A (author), Freitas, D (author), Macedo, G (author), Noronha, R (author), Cotter, J (author), Meliço-Silvestre, A (author), Peixe, R (author), Pratas, J (author), Barrote, D (author), Teixeira, R (author), Augusto, F (author), Carrilho, I (author), Campante, F (author), Velosa, J (author), Carvalho, L (author), Duarte, M (author), Guerreiro, H (author), Pires, C (author), Silva, A (author), Cotrim, I (author), Guedes, F (author), Tomé, L (author), Marcelino, M (author), Gonçalves, C (author), Ferreira, E (author), Matos, L (author), Peixe, P (author), Esteves, J (author), Valente, T (author), Simões, C (author), Marinho, C (author), Jasmins, L (author), Vieira, M (author), Marinho, R (author), Matos, P (author), Estevans, J (author), Carrasquinho, J (author), Salsedo, G (author), Parada, P (author), Teixeira, C (author)
Format: article
Language:eng
Published: 2012
Subjects:
Chronic hepatitis B
Antiviral agents
Lamivudine
Portugal
Online Access:http://hdl.handle.net/10400.10/827
Country:Portugal
Oai:oai:repositorio.hff.min-saude.pt:10400.10/827

Internet

http://hdl.handle.net/10400.10/827

Similar Items